Key facts
- It has raised $25.6M; the latest was Later Stage VC ($10.0M) in Oct 2025.
- Notable investors include ventureLAB Innovation Centre, Government of Canada, Business Development Bank of Canada, Invest Nova Scotia, Newfoundland Capital Management — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Stethophone
- ·The full record, as it builds
Funding rounds
No funding rounds for Stethophone are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Stethophone
Developer of a smartphone stethoscope designed to collect and collaborate on medical-grade cardiac and pulmonary data. The company leverages proprietary technology to integrate equitable and accurate health assessment into everyday life and recognize the slightest signs of disease, enabling cardiologists to reduce the chances of heart and lung diseases.
- Sector
- Healthcare
- HQ
- Saint Johns, Canada
- Founded
- 2019
- Employees
- 25
- Website
- stethophone.com/
- Ownership
- Privately Held (backing)
Stethophone doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Stethophone shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Stethophone in its N-PORT filings yet. We sweep new filings monthly.